Alexion Pharmaceuticals Merger Agreements

9 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
OMITTED INFORMATION IS THE SUBJECT OF A REQUEST FOR CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 AND HAS BEEN FILED SEPARATELY WITH THE...
Merger Agreements
Alexion Pharmaceuticals
Biotechnology
DE
2012
AGREEMENT AND PLAN OF MERGER dated as of December12, 2020 among ASTRAZENECA PLC, DELTA OMEGA SUB HOLDINGS INC., DELTA OMEGA SUB HOLDINGS INC. 1, DELTA OMEGA SUB HOLDINGS LLC 2 and...
Merger Agreements
Alexion Pharmaceuticals
Biotechnology
NY
2020
Agreement and Plan of Merger, dated as of May 5, 2020, by and among Portola Pharmaceuticals, Inc., Alexion Pharmaceuticals, Inc. and Odyssey Merger Sub Inc
Merger Agreements
Alexion Pharmaceuticals
Biotechnology
DE
2020
Agreement and Plan of Merger, dated October 15, 2019, by and among Alexion, Beagle Merger Sub, Inc. and Achillion
Merger Agreements
Alexion Pharmaceuticals
Biotechnology
DE
2019
Agreement, dated as of September 7, 2018, by and between Alexion Pharma Holding Unlimited Company, Shareholder Representative Services LLC, Fonds de Solidarit des Travailleurs du...
Merger Agreements
Alexion Pharmaceuticals
Biotechnology
2018
Agreement and Plan of Merger, dated as of September 25, 2018, by and among Alexion Pharmaceuticals, Inc., Syracuse Merger Sub, Inc., Syntimmune, Inc. and Shareholder...
Merger Agreements
Alexion Pharmaceuticals
Biotechnology
CO
2018
AGREEMENT AND PLAN OF REORGANIZATION by and among ALEXION PHARMACEUTICALS, INC., PULSAR MERGER SUB INC., GALAXY MERGER SUB LLC, and SYNAGEVA BIOPHARMA CORP. Dated as of May 5, 2015
Merger Agreements
Alexion Pharmaceuticals
Biotechnology
DE
2015
FIRST AMENDMENT TO AGREEMENT AND PLAN OF MERGER
Merger Agreements
Alexion Pharmaceuticals
Biotechnology
2012
OMITTED INFORMATION IS THE SUBJECT OF A REQUEST FOR CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 AND HAS BEEN FILED SEPARATELY WITH THE...
Merger Agreements
Alexion Pharmaceuticals
Biotechnology
DE
2011